Patent · US Active

Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia

US8835359B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

Sanofi · FR

Inventors

Mathias Gebauer · Frankfurt, DE
Martin Michaelis · Frankfurt, DE
Danping Ding-Pfennigdorff · Frankfurt am Main, DE
Anke M. Schulte · Frankfurt am Main, DE
Daniel Ziemek · Watertown, US
Christiane Metz-Weldmann · Frankfurt am Main, DE

Key dates

Filing date	May 24, 2011
Grant date	Sep 16, 2014
Priority date	—
Expiry date	May 24, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a method of identifying a compound involved in pain, the use of Ctla2b nucleic acid or Ctla2b protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.